| Literature DB >> 34312154 |
Diwakar Mohan1, Kerry Scott2, Neha Shah2, Jean Juste Harrisson Bashingwa3, Arpita Chakraborty4, Osama Ummer5, Anna Godfrey6, Priyanka Dutt4, Sara Chamberlain4, Amnesty Elizabeth LeFevre2,7.
Abstract
Kilkari is one of the largest maternal mobile messaging programmes in the world. It makes weekly prerecorded calls to new and expectant mothers and their families from the fourth month of pregnancy until 1-year post partum. The programme delivers reproductive, maternal, neonatal and child health information directly to subscribers' phones. However, little is known about the reach of Kilkari among different subgroups in the population, or the differentiated benefits of the programme among these subgroups. In this analysis, we assess differentials in eligibility, enrolment, reach, exposure and impact across well-known proxies of socioeconomic position-that is, education, caste and wealth. Data are drawn from a randomised controlled trial (RCT) in Madhya Pradesh, India, including call data records from Kilkari subscribers in the RCT intervention arm, and the National Family Health Survey-4, 2015. The analysis identifies that disparities in household phone ownership and women's access to phones create inequities in the population eligible to receive Kilkari, and that among enrolled Kilkari subscribers, marginalised caste groups and those without education are under-represented. An analysis of who is left behind by such interventions and how to reach those groups through alternative communication channels and platforms should be undertaken at the intervention design phase to set reasonable expectations of impact. Results suggest that exposure to Kilkari has improved levels of some health behaviours across marginalised groups but has not completely closed pre-existing gaps in indicators such as wealth and education. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: Epidemiology; Maternal health; Public Health
Mesh:
Year: 2021 PMID: 34312154 DOI: 10.1136/bmjgh-2021-005512
Source DB: PubMed Journal: BMJ Glob Health ISSN: 2059-7908